ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Entyvio subkutan 108 mg, Injektionslösung in einem Fertigpen - 
67534001 Takeda Pharma AG
Entyvio subkutan 108 mg, Injektionslösung in einem Fertigpen16.10.2020
  16.10.2020
Vedolizumab (L04AA33) 
WHO-DDD15.10.2025
07.15. 
07.15. 
A  
Yes 
IPCI
544.26Yes
    
10 %608.35
  
7680675340019Biotechnologika
  
Composition
vedolizumabum 108 mg, acidum citricum monohydricum, natrii citras dihydricus corresp. natrium 1.11 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.68 ml.
Packungsbestandteile
Injektionslösung in einem Fertigpen 
  
 
Active AgentDose
Vedolizumabum108mg / 0.68ml
BAG: Active AgentDose
Vedolizumabum108 mg
 
Inactive agents
Acidum Citricum Monohydricum
Arginini Hydrochloridum
Histidini Hydrochloridum Monohydricum
Histidinum
Natrii Citras Dihydricus
Polysorbatum 80
 
Source
Data was imported : 07.08.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home